JAMA : the journal of the American Medical Association
-
Randomized Controlled Trial Multicenter Study
Efficacy of Liraglutide for Weight Loss Among Patients With Type 2 Diabetes: The SCALE Diabetes Randomized Clinical Trial.
Weight loss of 5% to 10% can improve type 2 diabetes and related comorbidities. Few safe, effective weight-management drugs are currently available. ⋯ Among overweight and obese participants with type 2 diabetes, use of subcutaneous liraglutide (3.0 mg) daily, compared with placebo, resulted in weight loss over 56 weeks. Further studies are needed to evaluate longer-term efficacy and safety.
-
Biography Historical Article
Les buveurs d'absinthe (The Absinthe Drinkers): Jean-François Raffaëlli.